Cargando…
Analgesic therapy for headache: consumption, appropriateness and costs
Headache represents not only an individual disease, but also an important pathology for society because its prevalence in the population is about 50.0%. Its physical, emotional, social and economic impacts are often neglected and it is only recently that headache is being considered in a public heal...
Autores principales: | Iannazzo, Stefania, Cattaruzza, Maria S., De Filippis, Sergio, Rossi, Flora, Perata, Edea, Di Rollo, Samanta, Coloprisco, Gabriella, Martelletti, Paolo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag Italia
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3611688/ http://dx.doi.org/10.1007/s101940300018 |
Ejemplares similares
-
Reduction in expenditures on
analgesics during one year of treatment of chronic tension
headache with BoNT-A
por: Coloprisco, Gabriella, et al.
Publicado: (2003) -
Headache and mood disorders
por: De Filippis, S., et al.
Publicado: (2005) -
Long-term benefits of botulinum toxin type A
(BOTOX) in chronic daily headache: a five-year
long experience
por: Farinelli, I., et al.
Publicado: (2006) -
A one-year prospective costing study of botulinum toxin type A treatment of chronic tension headache
por: Palazzo, Fabio, et al.
Publicado: (2004) -
A one-year retrospective economic evaluation of botulinum toxin type A treatment of chronic tension headache
por: Mennini, Francesco S., et al.
Publicado: (2004)